Blogs

  1. PINK-"An Imminent Hazard to Public Safety"

    LAW ENFORCEMENT SENSITIVE 400 SOUTH MAIN ST, 3 FLOOR | LONDON, KY 40741 ■ PHONE: 606.877.2133 RD January 2019 PINK – “An Imminent Hazard to Public Safety” In 2016 the DEA first encountered the synthetic opioid U-47700, street named “Pink” or “Pinky”, which was later determined to be a potent mixture of U-47700 and heroin. U-47700 is synthetic opioid approximately 7.5 times stronger than morphine which is now classified as a Schedule I by the Controlled Substances Act. The DEA’s 2017 National...
  2. Meth’s resurgence spotlights lack of meds to combat the addiction

    By Carmen Rodriguez January 14, 2019 In 2016, news reports warned the public of an opioid epidemic gripping the nation. But Madeline Vaughn, then a lead clinical intake coordinator at the Houston-based addiction treatment organization Council on Recovery, sensed something different was going on with the patients she checked in from the street. Their behavior, marked by twitchy suspicion, a poor memory, and the feeling that someone was following them, signaled that the people coming...
  3. The Interconnectivity of Things, or "How the Hell Did THAT Happen?"

    Well, it has been quite some time since I added anything to my blog. Actually, it has been quite some time since I wrote anything at all! Unless maybe you count my recovery journal, but that was only for a month or three. And the occasional post over in the Paganism group, I guess. But anyway, as this is my first attempt at writing something interesting in a while, I expect it to be all over the place and probably not as "tight" as some of my other essays and works of madness. But I will get...
  4. The 6 S's of a psychedelic journey - Set - Setting - Substance - Sitter - Session - Situation

    Adapted From Chapter 19 of The Psychedelic Explorer’s Guide by Jim Fadiman If you have any familiarity with LSD use, you’ve probably heard the expression “Set and Setting.” It was coined by Norman Zinberg to describe the context for psychedelic drug experience and has become widely accepted by researchers in psychedelic therapy. Unknown to most others, however, are four other S’s: substance, sitter, session, and situation. Although these four S’s do not play as primary a role as Set and...
  5. Self love: The lesson through which all other lessons are realized

    Self Love: The Lesson Through Which All Other Lessons Are Realized Teal Swan [URL]https://tealswan.com/resources/articles/self-love-the-lesson-through-which-all-other-lessons-are-realized/[/URL] There is a wholeness that calls to all people, we are born with its song ringing in our ears, and yet we come to know it first by its absence. For most people, the time comes in adulthood when the emptiness within us grows so large it can not be filled externally. And running from fears becomes a fight that we...
  6. A Radical New Approach to Beating Addiction

    Psychedelic drugs are in the vanguard of treatment for addiction, raising the paradoxical question of how one mind-altering substance can override dependence on another. By Jennifer Bleyer, published May 2, 2017 - last reviewed on May 9, 2017 Jason didn't fit the hackneyed stereotype of an alcoholic. A 39-year-old marketing executive with a master's degree, he never blacked out or erupted in a stormy rage. His family's home in Albuquerque wasn't strewn with empty liquor bottles. He had...
  7. Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich

    Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary Ben Sessa and Friederike Meckel Fischer Abstract Underground psychedelic-assisted psychotherapy has persisted in Europe despite the banning of the substances LSD and MDMA in the 1960s and 1980s, respectively. This article describes the work of a Zurich-based psychotherapist providing individual and group psycholytic psychotherapy, whose practice persisted for several...
  8. Long-term systemic treatment with lysergic acid diethylamide causes retinal damage in CD1 mice

    As a classical hallucinogen with high potential for abuse, lysergic acid diethylamide (LSD) can cause long-lasting abnormalities in retina, but little is known about the exact mechanism. This study was to investigate effects of long-term systemic treatment of LSD at low dose on retinal damage and understand the underlying mechanisms. CD1 mice were treated intraperitoneally with 0.1 mg/kg or 0.2 mg/kg LSD daily for 2 months, mice treated with saline as negative control. Electroretinography...
  9. Ultimate Kratom Tea Recipe Discovered By The Drugs Forum Chancellor Of Space Drugs

    After numerous trials and tribulations, the Drugs Forum Chancellor of Space Drugs has discovered the perfect Kratom Tea recipe. The recipe simply requires 1 pot, water, 4 packs of hot cocoa, lemon juice, 10-15 grams of Kratom (preferably red vein Borneo or Bali if you want to get super relaxed), a stirring spoon, a metal coffee filter aka permanent coffee filter, and a cup big enough that you can put the metal coffee filter into it. ***Please do not skip the permanent coffee filter, trying...
  10. Treatment of Childhood Schizophrenia Utilizing LSD and Psilocybin

    From the Newsletter of the Multidisciplinary Association for Psychedelic Studies MAPS - Volume 7 Number 3 Summer 1997 - pp. 18-25 Treatment of Childhood Schizophrenia Utilizing LSD and Psilocybin Gary Fisher, Ph.D. Now that the FDA has permitted research with LSD and psilocybin to resume, we feel it is important to share examples of a remarkable experiment, the results of which were not sufficiently taken into account because this line of research was prematurely halted in the...
  11. The comeback of psychedelic science

    Psychedelic science is making a comeback. Scientific publications, therapeutic breakthroughs and cultural endorsements suggest that the historical reputation of psychedelics —such as lysergic acid diethylamide (LSD), mescaline (from the peyote cactus) and psilocybin (mushrooms) —as dangerous or inherently risky have unfairly overshadowed a more optimistic interpretation. Recent publications, like Michael Pollan's How to Change your Mind, showcase the creative and potentially therapeutic...
  12. A case report “A Physician’s Attempt to Self-Medicate Bipolar Depression with DMT

    Journal name: Journal of Psychoactive Drugs Here’s what happened when a psychiatrist tried to treat his depression by smoking DMT every day By Eric W. Dolan July 9, 2017 A case report recently published in the Journal of Psychoactive Drugs chronicles the story of a 40-year-old retired male psychiatrist who tried to treat his bipolar disorder using a powerful psychedelic drug called N,N-dimethyltryptamine (DMT). DMT was first synthesized by the chemist Richard H. F. Manske in 1931....
  13. Here's why we must continue to study Kratom and other opioid-like drugs

    The Hill, published July 8, 2018 by Paula N. Brown The U.S. Food and Drug Administration (FDA) recently gave final approval for the first non-opioid drug shown to lessen the severity of opioid withdrawal symptoms. Meanwhile, President Trump signed into law groundbreaking “right to try” legislation allowing the terminally ill to explore unapproved medical treatments as a last resort. In light of these developments, researchers and advocates of the botanical Kratom were hopeful for increased...
  14. Magic mushrooms may help with depression, say leading scientists

    Active ingredient could allow sufferers to relive happier times, says team including former government adviser David Nutt Magic mushrooms' active ingredient psilocybin enables users to experience more vivid recollections. Photograph: Peter Dejong/AP A drug derived from magic mushrooms could help people with depression by enabling them to relive positive and happy moments of their lives, according to scientists including the former government drug adviser, Professor David Nutt. Two studies,...
  15. Could LSD be the newest treatment for depression?

    Serotonin pathways activated by hallucinogens parallel those of antidepressants According to a study at the University of Basel, lysergic acid diethylamide, or “LSD,” a psychedelic drug, could be used as a form of treatment for depression and other mood disorders. Although current research on the underlying mechanisms of hallucinogens like LSD is lacking, recent findings show that it interferes with serotonin — a neurotransmitter related to mood and appetite regulation — much like common...
Loading...